ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,422 | +31.3% | 1,731 | +72.6% | 0.00% | – |
| Q2 2023 | $1,845 | -24.3% | 1,003 | 0.0% | 0.00% | – |
| Q1 2023 | $2,437 | +143.7% | 1,003 | +37.8% | 0.00% | – |
| Q4 2022 | $1,000 | -50.0% | 728 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 728 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 728 | -21.3% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 925 | -5.3% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 977 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 977 | -43.5% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 1,728 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 1,728 | -40.8% | 0.00% | – |
| Q4 2020 | $8,000 | -50.0% | 2,917 | -61.2% | 0.00% | – |
| Q3 2020 | $16,000 | +128.6% | 7,526 | +148.7% | 0.00% | – |
| Q2 2020 | $7,000 | -12.5% | 3,026 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | – | 3,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,312,792 | $22,991,000 | 4.49% |
| First Light Asset Management, LLC | 1,007,357 | $6,991,000 | 3.07% |
| KOPP INVESTMENT ADVISORS LLC | 211,974 | $1,471,000 | 1.55% |
| GLOBEFLEX CAPITAL L P | 223,931 | $1,554,000 | 0.39% |
| Nine Chapters Capital Management LLC | 30,900 | $214,000 | 0.36% |
| KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $486,000 | 0.35% |
| Campbell & CO Investment Adviser LLC | 11,513 | $80,000 | 0.25% |
| EAM Investors, LLC | 259,914 | $1,804,000 | 0.24% |
| Teza Capital Management LLC | 14,636 | $102,000 | 0.14% |
| Acrospire Investment Management LLC | 46,220 | $321,000 | 0.13% |